#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
CRP.3000518.AP009048.4153663_4154296.461	CRP.3000518.AP009048.4153663_4154296.461	1	0	539	1086	CRP	633	633	99.53	CRP.l15.c4.ctg.1	1093	53.4	0	.	p	.	0	K29T	NONSYN	85	87	AAG	307	309	ACG	60;60;60	A;C;G	60;60;60	.	CRP is a global regulator that represses MdtEF multidrug efflux pump expression.;CRP
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	3918	Escherichia_coli_EF_Tu	1230	1211	99.67	Escherichia_coli_EF_Tu.l15.c30.ctg.1	1389	139.9	1	SNP	p	R234F	1	.	.	700	702	TTC	878	880	TTC	182;181;181	T;T;C	181;181;181	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356:1:1:R234F:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to Pulvomycin	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	3918	Escherichia_coli_EF_Tu	1230	1211	99.67	Escherichia_coli_EF_Tu.l15.c30.ctg.1	1389	139.9	1	SNP	p	R334C	0	.	.	1000	1002	CGT	1178	1180	CGT	178;178;181	C;G;T	175;178;181	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356:1:1:R334C:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to Pulvomycin	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	3918	Escherichia_coli_EF_Tu	1230	1211	99.67	Escherichia_coli_EF_Tu.l15.c30.ctg.1	1389	139.9	0	HET	.	.	.	T180C	.	180	180	T	358	358	T	89	T,C	45,34	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	3918	Escherichia_coli_EF_Tu	1230	1211	99.67	Escherichia_coli_EF_Tu.l15.c30.ctg.1	1389	139.9	0	HET	.	.	.	C261T,G	.	261	261	C	439	439	C	186	C,T,G	105,77,1	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	3918	Escherichia_coli_EF_Tu	1230	1211	99.67	Escherichia_coli_EF_Tu.l15.c30.ctg.1	1389	139.9	0	HET	.	.	.	T999C	.	999	999	T	1177	1177	T	173	T,C	91,81	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	3918	Escherichia_coli_EF_Tu	1230	72	100.0	Escherichia_coli_EF_Tu.l15.c30.ctg.2	180	17.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	1	1	27	2336	Escherichia_coli_mutant	1392	1392	99.43	Escherichia_coli_mutant.l15.c30.ctg.1	1784	70.5	1	SNP	p	E350Q	0	.	.	1048	1050	GAA	1245	1247	GAA	75;75;74	G;A;A	75;75;74	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667:1:1:E350Q:.:Mutations to the active importer UhpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant UhpT conferring resistance to fosfomycin
H_NS.3000676.NC_002695.1737553_1737967.218	H_NS.3000676.NC_002695.1737553_1737967.218	1	0	27	294	H_NS	414	414	99.03	H_NS.l15.c30.ctg.1	587	25.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	H-NS;H-NS is a histone-like protein involved in global gene regulation in Gram-negative bacteria. It is a repressor of the membrane fusion protein genes acrE, mdtE, and emrK as well as nearby genes of many RND-type multidrug exporters.
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	1510	PmrB_1	1092	1092	99.08	PmrB_1.l15.c30.ctg.1	1540	52.8	0	.	p	.	0	H2R	NONSYN	4	6	CAT	269	271	CGT	34;39;38	C;G;T	34;39;38	.	PmrB;Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+)
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	1510	PmrB_1	1092	1092	99.08	PmrB_1.l15.c30.ctg.1	1540	52.8	0	.	p	.	0	V30I	NONSYN	88	90	GTC	353	355	ATC	46;48;47	A;T;C	46;48;47	.	PmrB;Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+)
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	1510	PmrB_1	1092	1092	99.08	PmrB_1.l15.c30.ctg.1	1540	52.8	0	.	p	.	0	D283G	NONSYN	847	849	GAC	1112	1114	GGC	75;75;78	G;G;C	75;75;78	.	PmrB;Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+)
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	2100	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2060	54.7	0	.	p	.	0	R8S	NONSYN	22	24	AGA	221	223	AGC	23;24;25	A;G;C,A	23;24;24,1	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	2100	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2060	54.7	0	.	p	.	0	I142L	NONSYN	424	426	ATA	623	625	CTA	55;55;56	C;T;A	55;55;56	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	2100	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2060	54.7	0	.	p	.	0	R315Q	NONSYN	943	945	CGA	1142	1144	CAA	85;88;91	C;A;A	85;88;91	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	2100	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2060	54.7	0	.	p	.	0	D348G	NONSYN	1042	1044	GAT	1241	1243	GGT	107;106;105	G;G;T	107;106;105	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	2100	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2060	54.7	0	.	p	.	0	I538V	NONSYN	1612	1614	ATT	1811	1813	GTT	27;26;26	G;T;T	27;25;26	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	844	PmrE	1167	1167	96.83	PmrE.l15.c4.ctg.1	1562	29.0	0	.	p	.	0	A125E	NONSYN	373	375	GCA	578	580	GAA	25;25;25	G;A;A	25;25;25	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	844	PmrE	1167	1167	96.83	PmrE.l15.c4.ctg.1	1562	29.0	0	.	p	.	0	M185T	NONSYN	553	555	ATG	758	760	ACC	17;17;17	A;C;C	17;17;17	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	844	PmrE	1167	1167	96.83	PmrE.l15.c4.ctg.1	1562	29.0	0	.	p	.	0	S225T	NONSYN	673	675	TCC	878	880	ACT	24;24;23	A;C;T	24;24;23	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	844	PmrE	1167	1167	96.83	PmrE.l15.c4.ctg.1	1562	29.0	0	.	p	.	0	T355I	NONSYN	1063	1065	ACC	1268	1270	ATC	13;14;14	A;T;C	13;14;14	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	3050	acrD	3114	3114	99.1	acrD.l15.c30.ctg.1	3543	46.3	0	.	p	.	0	T85I	NONSYN	253	255	ACC	507	509	ATC	38;36;37	A;T;C	38;36;37	.	acrD;AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	3050	acrD	3114	3114	99.1	acrD.l15.c30.ctg.1	3543	46.3	0	.	p	.	0	Q656K	NONSYN	1966	1968	CAA	2220	2222	AAG	37;39;38	A;A;G	37;39;37	.	acrD;AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	1454	acrE	1158	1158	98.79	acrE.l15.c30.ctg.1	1586	49.4	0	.	p	.	0	A22V	NONSYN	64	66	GCC	265	267	GTC	15;16;16	G;T;C	15;16;16	.	acrE;AcrE is a membrane fusion protein, similar to AcrA.
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	1454	acrE	1158	1158	98.79	acrE.l15.c30.ctg.1	1586	49.4	0	.	p	.	0	S269C	NONSYN	805	807	AGC	1006	1008	TGC	53;53;56	T;G;C	53;53;56	.	acrE;AcrE is a membrane fusion protein, similar to AcrA.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	3324	acrF	3105	2598	98.5	acrF.l15.c30.ctg.1	3030	58.5	0	.	p	.	0	S46trunc	TRUNC	136	136	T	364	364	T	45	T	45	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	3324	acrF	3105	2598	98.5	acrF.l15.c30.ctg.1	3030	58.5	0	.	p	.	0	G148D	NONSYN	442	444	GGC	670	672	GAC	59;59;60	G;A;C	58;58;60	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	3324	acrF	3105	2598	98.5	acrF.l15.c30.ctg.1	3030	58.5	0	.	p	.	0	F240L	NONSYN	718	720	TTT	946	948	TTA	21;21;21	T;T;A	21;21;21	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	3324	acrF	3105	2598	98.5	acrF.l15.c30.ctg.1	3030	58.5	0	.	p	.	0	D301N	NONSYN	901	903	GAT	1129	1131	AAT	34;34;35	A;A;T	31;33;34	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	3324	acrF	3105	2598	98.5	acrF.l15.c30.ctg.1	3030	58.5	0	.	p	.	0	L563fs	FSHIFT	1687	1687	T	1916	1916	T	63	T	63	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrR.3003807.NC_000913.3.485760_486408.3575	acrR.3003807.NC_000913.3.485760_486408.3575	1	1	27	712	acrR_2	648	648	99.54	acrR_2.l15.c17.ctg.1	1052	36.3	1	SNP	p	R45C	0	.	.	133	135	CGC	335	337	CGC	52;49;51	C;G;C	51;49;51	acrR.3003807.NC_000913.3.485760_486408.3575:1:1:R45C:.:AcrR is a repressor of the AcrAB-TolC multidrug efflux complex. AcrR mutations result in high level antibiotic resistance. The mutations associated with this model are specific to E. coli.	Escherichia coli acrR mutants resulting in antibiotic resistance
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	690	acrS	663	663	98.64	acrS.l15.c30.ctg.1	928	39.2	0	.	p	.	0	L34F	NONSYN	100	102	CTC	227	229	TTC	49;48;48	T;T;C	49;48;48	.	acrS;AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	690	acrS	663	663	98.64	acrS.l15.c30.ctg.1	928	39.2	0	.	p	.	0	E122G	NONSYN	364	366	GAG	491	493	GGG	42;44;43	G;G;G	41;44;43	.	acrS;AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.
adiY.3003828.NC_000913.3.4337167_4337929.3591	adiY.3003828.NC_000913.3.4337167_4337929.3591	1	0	539	1042	adiY	762	762	99.61	adiY.l6.c30.ctg.1	1197	46.8	0	.	p	.	0	V136L	NONSYN	406	408	GTT	635	637	CTT	56;54;56	C;T;T	56;54;56	.	adiY;adiY is a DNA-binding transcriptional activator of the adi system. Implicated in arginine-dependent acid resistance in Escherichia coli.
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	3606	alaS	2631	2631	98.86	alaS.l15.c4.ctg.1	3071	63.1	0	.	p	.	0	T618A	NONSYN	1852	1854	ACA	2053	2055	GCA	88;88;89	G;C;A	88;88;89	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	3606	alaS	2631	2631	98.86	alaS.l15.c4.ctg.1	3071	63.1	0	.	p	.	0	A705T	NONSYN	2113	2115	GCC	2314	2316	ACC	83;84;83	A;C;C	79;84;82	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	3606	alaS	2631	2631	98.86	alaS.l15.c4.ctg.1	3071	63.1	0	.	p	.	0	V808A	NONSYN	2422	2424	GTC	2623	2625	GCC	52;52;52	G;C,G;C	52;50,1;51	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	1204	bacA	822	822	98.54	bacA.l15.c17.ctg.1	1056	58.6	0	.	p	.	0	S221T	NONSYN	661	663	AGC	853	855	ACC	24;23;26	A;C;C	24;23;26	.	bacA;bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	1204	bacA	822	822	98.54	bacA.l15.c17.ctg.1	1056	58.6	0	.	p	.	0	P225S	NONSYN	673	675	CCG	865	867	TCG	32;31;32	T;C,A;G	32;30,1;31	.	bacA;bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin
baeR.3000828.NC_007779.2166412_2167135.676	baeR.3000828.NC_007779.2166412_2167135.676	1	0	27	560	baeR	723	723	97.79	baeR.l15.c30.ctg.1	1190	25.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	BaeR is a response regulator that promotes the expression of MdtABC and AcrD efflux complexes.;baeR
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	1150	baeS	1404	1404	98.86	baeS.l15.c30.ctg.1	1606	37.7	0	.	p	.	0	Q376K	NONSYN	1126	1128	CAA	1317	1319	AAA	24;24;24	A;A;A	23;23;24	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	1150	baeS	1404	1404	98.86	baeS.l15.c30.ctg.1	1606	37.7	0	.	p	.	0	G380E	NONSYN	1138	1140	GGG	1329	1331	GAG	21;21;22	G;A;G	20;18;20	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	1150	baeS	1404	1404	98.86	baeS.l15.c30.ctg.1	1606	37.7	0	.	p	.	0	R382H	NONSYN	1144	1146	CGC	1335	1337	CAC	23;24;23	C;A;C	22;22;22	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	1150	baeS	1404	1404	98.86	baeS.l15.c30.ctg.1	1606	37.7	0	.	p	.	0	D400E	NONSYN	1198	1200	GAT	1389	1391	GAG	17;19;20	G;A;G	17;19;20	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
cpxA.3000830.NC_002695.4903561_4904935.605	cpxA.3000830.NC_002695.4903561_4904935.605	1	0	27	1682	cpxA	1374	1374	98.91	cpxA.l15.c30.ctg.1	1863	48.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	cpxA;CpxA is a membrane-localized sensor kinase that is activated by envelope stress. It starts a kinase cascade that activates CpxR, which promotes efflux complex expression.
cpxR.3000831.NC_002695.4904931_4905630.142	cpxR.3000831.NC_002695.4904931_4905630.142	1	0	27	1124	cpxR	699	699	99.43	cpxR.l15.c17.ctg.1	1160	52.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	CpxR is a regulator that promotes acrD expression when phosphorylated by a cascade involving CpxA, a sensor kinase.;cpxR
cysB.3003840.NC_000913.3.1333854_1334829.3604	cysB.3003840.NC_000913.3.1333854_1334829.3604	1	0	539	766	cysB	975	975	99.28	cysB.l6.c30.ctg.1	1441	28.6	0	.	p	.	0	A146T	NONSYN	436	438	GCT	685	687	ACT	28;27;28	A;C;T	28;27;28	.	Positive regulator of gene expression in the cysteine regulon. cysB mutants confer resistance to novobiocin, an aminocoumarin antibiotic, in Escherichia coli.;aminocoumarin resistant cysB
emrA.3000027.AP009048.2810082_2811255.411	emrA.3000027.AP009048.2810082_2811255.411	1	0	539	1400	emrA	1173	1173	98.29	emrA.l15.c4.ctg.1	1641	45.7	0	.	p	.	0	I219V	NONSYN	655	657	ATC	899	901	GTC	74;73;74	G;T;C	70;72;73	.	emrA;EmrA is a membrane fusion protein, providing an efflux pathway with EmrB and TolC between the inner and outer membranes of E. coli, a Gram-negative bacterium.
emrB.3000074.U00096.2812615_2814154.20	emrB.3000074.U00096.2812615_2814154.20	1	0	539	1944	emrB	1539	1539	99.74	emrB.l15.c4.ctg.1	2031	51.4	0	.	p	.	0	E197K	NONSYN	589	591	GAA	856	858	AAA	64;62;63	A;A;A	64;61;63	.	emrB is a translocase in the emrB -TolC efflux protein in E. coli. It recognizes substrates including carbonyl cyanide m-chlorophenylhydrazone (CCCP), nalidixic acid, and thioloactomycin.;emrB
emrD.3000309.GG749185.1.116812_118003.3622	emrD.3000309.GG749185.1.116812_118003.3622	1	0	539	1728	emrD	1191	1191	98.4	emrD.l15.c17.ctg.1	1723	54.1	0	.	p	.	0	G209S	NONSYN	625	627	GGC	899	901	AGC	43;46;44	A;G;C	43;46;44	.	EmrD is a multidrug transporter from the Major Facilitator Superfamily (MFS) primarily found in Escherichia coli. EmrD couples efflux of amphipathic compounds with proton import across the plasma membrane.;emrD
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	968	emrK	1056	1056	98.2	emrK.l15.c30.ctg.1	1494	34.9	0	.	p	.	0	K176R	NONSYN	526	528	AAG	738	740	AGG	33;35;35	A;G;G	33;35;35	.	emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.;emrK
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	968	emrK	1056	1056	98.2	emrK.l15.c30.ctg.1	1494	34.9	0	.	p	.	0	N306D	NONSYN	916	918	AAC	1128	1130	GAC	23;23;24	G;A;C	23;23;24	.	emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.;emrK
emrR.3000516.NC_000913.3.2810769_2811300.3621	emrR.3000516.NC_000913.3.2810769_2811300.3621	1	0	27	778	emrR	531	531	100.0	emrR.l15.c30.ctg.1	1031	40.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrR;EmrR is a negative regulator for the EmrAB-TolC multidrug efflux pump in E. coli. Mutations lead to EmrAB-TolC overexpression.
emrY.3000254.D78168.1591_3130.65	emrY.3000254.D78168.1591_3130.65	1	0	539	1452	emrY	1539	1539	99.74	emrY.l15.c30.ctg.1	2005	39.0	0	.	p	.	0	P385A	NONSYN	1153	1155	CCC	1409	1411	GCC	45;44;43	G;C;C	45;44;42	.	emrY;emrY is a multidrug transport that moves substrates across the inner membrane of the Gram-negative E. coli. It is a homolog of emrB.
evgA.3000832.NC_002695.3211891_3212506.208	evgA.3000832.NC_002695.3211891_3212506.208	1	0	539	586	evgA	615	615	99.19	evgA.l15.c30.ctg.1	856	34.5	0	.	p	.	0	Q62L	NONSYN	184	186	CAG	268	270	CTG	30;29;32	C;T;G	30;29;32	.	EvgA, when phosphorylated, is a positive regulator for efflux protein complexes emrKY and mdtEF. While usually phosphorylated in a EvgS dependent manner, it can be phosphorylated in the absence of EvgS when overexpressed.;evgA
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2756	evgS	3594	1073	97.3	evgS.l15.c30.ctg.1	1272	27.2	0	.	p	.	0	T38I	NONSYN	112	114	ACA	311	313	ATA	14;14;13	A;T;A	14;14;13	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2756	evgS	3594	1073	97.3	evgS.l15.c30.ctg.1	1272	27.2	0	.	p	.	0	L42V	NONSYN	124	126	CTA	323	325	GTA	17;18;20	G;T;A	17;18;20	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2756	evgS	3594	1073	97.3	evgS.l15.c30.ctg.1	1272	27.2	0	.	p	.	0	A93T	NONSYN	277	279	GCG	476	478	ACG	24;23;23	A;C;G	24;23;23	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2756	evgS	3594	1073	97.3	evgS.l15.c30.ctg.1	1272	27.2	0	.	p	.	0	A114E	NONSYN	340	342	GCA	539	541	GAA	44;45;46	G;A;A	44;45;46	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2756	evgS	3594	1073	97.3	evgS.l15.c30.ctg.1	1272	27.2	0	.	p	.	0	T127A	NONSYN	379	381	ACT	578	580	GCT	35;35;33	G;C;T	34;35;33	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2756	evgS	3594	1073	97.3	evgS.l15.c30.ctg.1	1272	27.2	0	.	p	.	0	N133D	NONSYN	397	399	AAT	596	598	GAT	20;20;19	G;A;T	20;20;17	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2756	evgS	3594	1073	97.3	evgS.l15.c30.ctg.1	1272	27.2	0	.	p	.	0	P162S	NONSYN	484	486	CCA	683	685	TCA	16;15;17	T;C;A	16;15;17	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2756	evgS	3594	1073	97.3	evgS.l15.c30.ctg.1	1272	27.2	0	.	p	.	0	H205Q	NONSYN	613	615	CAC	812	814	CAG	24;24;23	C;A;G	24;24;23	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2756	evgS	3594	1073	97.3	evgS.l15.c30.ctg.1	1272	27.2	0	.	p	.	0	I251V	NONSYN	751	753	ATT	950	952	GTT	34;34;34	G;T;T	34;34;34	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2756	evgS	3594	1073	97.3	evgS.l15.c30.ctg.1	1272	27.2	0	.	p	.	0	N303D	NONSYN	907	909	AAT	1106	1108	GAT	12;12;12	G;A;T	12;12;11	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2756	evgS	3594	2490	97.87	evgS.l15.c30.ctg.2	2789	40.6	0	.	p	.	0	Q433K	NONSYN	1297	1299	CAG	195	197	AAA	26;26;27	A;A;A	26;26;27	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2756	evgS	3594	2490	97.87	evgS.l15.c30.ctg.2	2789	40.6	0	.	p	.	0	N678H	NONSYN	2032	2034	AAT	930	932	CAT	37;36;35	C;A;T	37;36;35	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2756	evgS	3594	2490	97.87	evgS.l15.c30.ctg.2	2789	40.6	0	.	p	.	0	N696H	NONSYN	2086	2088	AAT	984	986	CAT	40;41;41	C;A;T	40;41;41	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2756	evgS	3594	2490	97.87	evgS.l15.c30.ctg.2	2789	40.6	0	.	p	.	0	K702R	NONSYN	2104	2106	AAA	1002	1004	AGA	42;44;44	A;G;A	42;43;44	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2756	evgS	3594	2490	97.87	evgS.l15.c30.ctg.2	2789	40.6	0	.	p	.	0	K707N	NONSYN	2119	2121	AAG	1017	1019	AAT	36;37;37	A;A;T	36;36;37	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2756	evgS	3594	2490	97.87	evgS.l15.c30.ctg.2	2789	40.6	0	.	p	.	0	A756S	NONSYN	2266	2268	GCC	1164	1166	TCC	16;14;15	T;C;C	16;14;15	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2756	evgS	3594	2490	97.87	evgS.l15.c30.ctg.2	2789	40.6	0	.	p	.	0	S811I	NONSYN	2431	2433	AGT	1329	1331	ATT	41;41;41	A;T;T	41;41;41	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2756	evgS	3594	2490	97.87	evgS.l15.c30.ctg.2	2789	40.6	0	.	p	.	0	E818D	NONSYN	2452	2454	GAA	1350	1352	GAT	32;31;32	G;A;T	32;31;32	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2756	evgS	3594	2490	97.87	evgS.l15.c30.ctg.2	2789	40.6	0	.	p	.	0	G856V	NONSYN	2566	2568	GGT	1464	1466	GTT	47;48;46	G;T;T	47;48;46	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2756	evgS	3594	2490	97.87	evgS.l15.c30.ctg.2	2789	40.6	0	.	p	.	0	Q951H	NONSYN	2851	2853	CAA	1749	1751	CAC	39;38;38	C;A;C,T	37;38;35,1	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	990	folP_1	849	849	99.29	folP_1.l15.c30.ctg.1	1264	42.0	1	SNP	p	P64L	0	.	.	190	192	CCA	415	417	CCA	81;79;81	C;C;A	81;79;80	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64L:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	990	folP_1	849	849	99.29	folP_1.l15.c30.ctg.1	1264	42.0	1	SNP	p	P64A	0	.	.	190	192	CCA	415	417	CCA	81;79;81	C;C;A	81;79;80	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64A:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	990	folP_1	849	849	99.29	folP_1.l15.c30.ctg.1	1264	42.0	1	SNP	p	P64H	0	.	.	190	192	CCA	415	417	CCA	81;79;81	C;C;A	81;79;80	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64H:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	990	folP_1	849	849	99.29	folP_1.l15.c30.ctg.1	1264	42.0	1	SNP	p	P64R	0	.	.	190	192	CCA	415	417	CCA	81;79;81	C;C;A	81;79;80	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64R:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	990	folP_1	849	849	99.29	folP_1.l15.c30.ctg.1	1264	42.0	1	SNP	p	P64S	0	.	.	190	192	CCA	415	417	CCA	81;79;81	C;C;A	81;79;80	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64S:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
gadE.3003834.NC_000913.3.3658365_3658893.3597	gadE.3003834.NC_000913.3.3658365_3658893.3597	1	0	27	916	gadE	528	528	100.0	gadE.l15.c17.ctg.1	973	50.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	gadE;gadE is a DNA-binding transcriptional activator that regulates the expression of genes involved in acid resistance. It is required for the expression of gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	222	gadW	729	130	97.69	gadW.l15.c17.ctg.1	130	36.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	222	gadW	729	308	93.18	gadW.l15.c17.ctg.2	309	10.8	0	.	p	.	0	E54D	NONSYN	160	162	GAA	11	13	GAT	4;5;5	G;A;T	4;5;5	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	222	gadW	729	308	93.18	gadW.l15.c17.ctg.2	309	10.8	0	.	p	.	0	I88M	NONSYN	262	264	ATA	113	115	ATG	7;7;7	A;T;G	7;7;7	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	222	gadW	729	308	93.18	gadW.l15.c17.ctg.2	309	10.8	0	.	p	.	0	Q89P	NONSYN	265	267	CAG	116	118	CCG	7;6;6	C;C;G	7;6;6	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	222	gadW	729	308	93.18	gadW.l15.c17.ctg.2	309	10.8	0	.	p	.	0	D100E	NONSYN	298	300	GAC	149	151	GAA	4;3;3	G;A;A	4;3;3	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	222	gadW	729	308	93.18	gadW.l15.c17.ctg.2	309	10.8	0	.	p	.	0	P101S	NONSYN	301	303	CCC	152	154	TCC	3;3;3	T;C;C	3;3;3	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	222	gadW	729	308	93.18	gadW.l15.c17.ctg.2	309	10.8	0	.	p	.	0	R102G	NONSYN	304	306	CGG	155	157	GGG	4;4;4	G;G;G	4;4;4	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	222	gadW	729	308	93.18	gadW.l15.c17.ctg.2	309	10.8	0	.	p	.	0	K110N	NONSYN	328	330	AAA	179	181	AAT	6;6;6	A;A;T	6;6;6	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	1062	gadX	825	825	97.94	gadX.l6.c30.ctg.1	1214	47.0	0	.	p	.	0	F53L	NONSYN	157	159	TTC	324	326	TTA	58;57;55	T;T;A	58;57;55	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	1062	gadX	825	825	97.94	gadX.l6.c30.ctg.1	1214	47.0	0	.	p	.	0	V79I	NONSYN	235	237	GTT	402	404	ATT	45;44;46	A;T;T	43;43;44	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	1062	gadX	825	825	97.94	gadX.l6.c30.ctg.1	1214	47.0	0	.	p	.	0	R246G	NONSYN	736	738	AGA	903	905	GGA	48;46;47	G;G;A	48;46;47	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	1062	gadX	825	825	97.94	gadX.l6.c30.ctg.1	1214	47.0	0	.	p	.	0	S248P	NONSYN	742	744	TCG	909	911	CCG	45;44;43	C;C;G	45;44;43	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	3094	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3151	52.9	0	.	p	.	0	D678E	NONSYN	2032	2034	GAC	2273	2275	GAA	58;59;62	G;A;A	58;58;62	.	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	3094	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3151	52.9	1	SNP	p	S83L	0	.	.	247	249	TCG	488	490	TCG	64;62;62	T;C;G	63;61;62	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83L:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	3094	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3151	52.9	1	SNP	p	S83W	0	.	.	247	249	TCG	488	490	TCG	64;62;62	T;C;G	63;61;62	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83W:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	3094	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3151	52.9	1	SNP	p	S83I	0	.	.	247	249	TCG	488	490	TCG	64;62;62	T;C;G	63;61;62	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83I:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	3094	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3151	52.9	1	SNP	p	D87G	0	.	.	259	261	GAC	500	502	GAC	57;58;54	G;A;C	56;58;54	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87G:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	3094	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3151	52.9	1	SNP	p	D87H	0	.	.	259	261	GAC	500	502	GAC	57;58;54	G;A;C	56;58;54	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87H:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	3094	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3151	52.9	1	SNP	p	D87Y	0	.	.	259	261	GAC	500	502	GAC	57;58;54	G;A;C	56;58;54	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87Y:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	3094	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3151	52.9	1	SNP	p	D87N	0	.	.	259	261	GAC	500	502	GAC	57;58;54	G;A;C	56;58;54	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87N:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	3094	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3151	52.9	1	SNP	p	D87V	0	.	.	259	261	GAC	500	502	GAC	57;58;54	G;A;C	56;58;54	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87V:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	3746	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2923	68.9	1	SNP	p	R136G	0	.	.	406	408	CGC	629	631	CGC	76;76;78	C;G;C	75;76;78	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136G:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	3746	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2923	68.9	1	SNP	p	R136C	0	.	.	406	408	CGC	629	631	CGC	76;76;78	C;G;C	75;76;78	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136C:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	3746	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2923	68.9	1	SNP	p	R136E	0	.	.	406	408	CGC	629	631	CGC	76;76;78	C;G;C	75;76;78	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136E:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	3746	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2923	68.9	1	SNP	p	R136H	0	.	.	406	408	CGC	629	631	CGC	76;76;78	C;G;C	75;76;78	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136H:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	3746	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2923	68.9	1	SNP	p	R136S	0	.	.	406	408	CGC	629	631	CGC	76;76;78	C;G;C	75;76;78	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136S:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	3746	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2923	68.9	1	SNP	p	R136I	0	.	.	406	408	CGC	629	631	CGC	76;76;78	C;G;C	75;76;78	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136I:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	3746	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2923	68.9	1	SNP	p	R136L	0	.	.	406	408	CGC	629	631	CGC	76;76;78	C;G;C	75;76;78	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136L:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	572	kdpE	678	678	98.23	kdpE.l15.c30.ctg.1	1060	29.1	0	.	p	.	0	A72P	NONSYN	214	216	GCG	465	467	CCG	49;49;48	C;C;G	49;48;48	.	kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.;kdpE
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	572	kdpE	678	678	98.23	kdpE.l15.c30.ctg.1	1060	29.1	0	.	p	.	0	T123A	NONSYN	367	369	ACC	618	620	GCC	39;37;37	G;C;C	39;37;36	.	kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.;kdpE
leuO.3003843.NC_000913.3.84367_85312.3607	leuO.3003843.NC_000913.3.84367_85312.3607	1	0	539	1144	leuO	945	945	99.26	leuO.l15.c30.ctg.1	1412	43.5	0	.	p	.	0	P9S	NONSYN	25	27	CCA	203	205	TCA	37;38;36	T;C;A	37;37;36	.	leuO, a LysR family transcription factor, exists in a wide variety of bacteria of the family Enterobacteriaceae and is involved in the regulation of as yet unidentified genes affecting the stress response and pathogenesis expression.;leuO
marA.3000263.NC_007779.1621287_1621671.579	marA.3000263.NC_007779.1621287_1621671.579	1	0	27	394	marA	384	384	99.74	marA.l15.c4.ctg.1	890	23.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	In the presence of antibiotic stress, E. coli overexpresses the global activator protein MarA, which besides inducing MDR efflux pump AcrAB, also down- regulates synthesis of the porin OmpF.;marA
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	282	marR	435	435	97.47	marR.l6.c17.ctg.1	809	18.7	1	SNP	p	G103S	1	G103S	NONSYN	307	309	GGC	518	520	AGC	26;25;24	A,G;G;C	25,1;25;24	marR.3003378.U00096.1619119_1619554.2097:1:1:G103S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	282	marR	435	435	97.47	marR.l6.c17.ctg.1	809	18.7	1	SNP	p	Y137H	1	Y137H	NONSYN	409	411	TAT	620	622	CAT	7;6;6	C;A;T	6;4;6	marR.3003378.U00096.1619119_1619554.2097:1:1:Y137H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	282	marR	435	435	97.47	marR.l6.c17.ctg.1	809	18.7	0	.	p	.	0	V142A	NONSYN	424	426	GTC	635	637	GCC	5;5;6	G;C,T;C	4;2,3;6	.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	282	marR	435	435	97.47	marR.l6.c17.ctg.1	809	18.7	1	SNP	p	V45E	0	.	.	133	135	GTG	344	346	GTG	49;49;49	G;T;G	48;47;49	marR.3003378.U00096.1619119_1619554.2097:1:1:V45E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	282	marR	435	435	97.47	marR.l6.c17.ctg.1	809	18.7	1	SNP	p	I49S	0	.	.	145	147	ATC	356	358	ATC	42;41;40	A;T;C	42;41;39	marR.3003378.U00096.1619119_1619554.2097:1:1:I49S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	282	marR	435	435	97.47	marR.l6.c17.ctg.1	809	18.7	1	SNP	p	A70T	0	.	.	208	210	GCA	419	421	GCA	26;27;27	G;C;A	26;27;27	marR.3003378.U00096.1619119_1619554.2097:1:1:A70T:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	282	marR	435	435	97.47	marR.l6.c17.ctg.1	809	18.7	1	SNP	p	R73S	0	.	.	217	219	CGT	428	430	CGT	25;25;25	C;G;T	25;24;25	marR.3003378.U00096.1619119_1619554.2097:1:1:R73S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	282	marR	435	435	97.47	marR.l6.c17.ctg.1	809	18.7	1	SNP	p	R73C	0	.	.	217	219	CGT	428	430	CGT	25;25;25	C;G;T	25;24;25	marR.3003378.U00096.1619119_1619554.2097:1:1:R73C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	282	marR	435	435	97.47	marR.l6.c17.ctg.1	809	18.7	1	SNP	p	R77C	0	.	.	229	231	CGC	440	442	CGC	28;28;28	C;G;C	28;27;28	marR.3003378.U00096.1619119_1619554.2097:1:1:R77C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	282	marR	435	435	97.47	marR.l6.c17.ctg.1	809	18.7	1	SNP	p	R77L	0	.	.	229	231	CGC	440	442	CGC	28;28;28	C;G;C	28;27;28	marR.3003378.U00096.1619119_1619554.2097:1:1:R77L:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	282	marR	435	435	97.47	marR.l6.c17.ctg.1	809	18.7	1	SNP	p	L78M	0	.	.	232	234	CTG	443	445	CTG	29;28;27	C;T;G	29;28;27	marR.3003378.U00096.1619119_1619554.2097:1:1:L78M:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	282	marR	435	435	97.47	marR.l6.c17.ctg.1	809	18.7	1	SNP	p	R94S	0	.	.	280	282	CGC	491	493	CGC	25;25;25	C;G;C	25;25;25	marR.3003378.U00096.1619119_1619554.2097:1:1:R94S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	282	marR	435	435	97.47	marR.l6.c17.ctg.1	809	18.7	1	SNP	p	R94H	0	.	.	280	282	CGC	491	493	CGC	25;25;25	C;G;C	25;25;25	marR.3003378.U00096.1619119_1619554.2097:1:1:R94H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	282	marR	435	435	97.47	marR.l6.c17.ctg.1	809	18.7	1	SNP	p	V96E	0	.	.	286	288	GTA	497	499	GTA	24;26;27	G;T;A	24;26;27	marR.3003378.U00096.1619119_1619554.2097:1:1:V96E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	794	mdtA	1248	1248	97.36	mdtA.l15.c4.ctg.1	1738	24.6	0	.	p	.	0	V12trunc	TRUNC	34	34	G	311	311	G	37	G	36	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	794	mdtA	1248	1248	97.36	mdtA.l15.c4.ctg.1	1738	24.6	0	.	p	.	0	R33Q	NONSYN	97	99	CGG	368	370	CAG	14;13;11	C;A;G	14;13;11	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	794	mdtA	1248	1248	97.36	mdtA.l15.c4.ctg.1	1738	24.6	0	.	p	.	0	T83I	NONSYN	247	249	ACC	518	520	ATC	24;23;20	A;T;C	23;22;20	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	794	mdtA	1248	1248	97.36	mdtA.l15.c4.ctg.1	1738	24.6	0	.	p	.	0	I99M	NONSYN	295	297	ATA	566	568	ATG	6;8;9	A;T;G	6;8;9	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	794	mdtA	1248	1248	97.36	mdtA.l15.c4.ctg.1	1738	24.6	0	.	p	.	0	A130T	NONSYN	388	390	GCC	659	661	ACC	21;21;20	A;C;C	21;21;20	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	794	mdtA	1248	1248	97.36	mdtA.l15.c4.ctg.1	1738	24.6	0	.	p	.	0	P257T	NONSYN	769	771	CCG	1040	1042	ACG	34;32;34	A,C;C;G	33,1;32;34	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	3152	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3495	48.5	0	.	p	.	0	A583T	NONSYN	1747	1749	GCC	1950	1952	ACC	52;50;49	A;C;C	52;50;49	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	3152	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3495	48.5	0	.	p	.	0	K714Q	NONSYN	2140	2142	AAA	2343	2345	CAA	29;28;29	C;A;A	29;28;28	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	3152	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3495	48.5	0	.	p	.	0	N770I	NONSYN	2308	2310	AAT	2511	2513	ATT	34;34;34	A;T;T	34;34;34	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	3152	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3495	48.5	0	.	p	.	0	I798V	NONSYN	2392	2394	ATT	2595	2597	GTT	55;54;57	G;T;T	54;52;56	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	3152	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3495	48.5	0	.	p	.	0	A834E	NONSYN	2500	2502	GCG	2703	2705	GAG	29;29;30	G;A;G	29;29;30	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	3152	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3495	48.5	0	.	p	.	0	L910M	NONSYN	2728	2730	CTG	2931	2933	ATG	20;21;24	A;T;G	20;21;24	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	3152	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3495	48.5	0	.	p	.	0	E955D	NONSYN	2863	2865	GAG	3066	3068	GAT	28;30;30	G;A;T	27;28;30	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	2718	mdtC	3078	3078	98.64	mdtC.l15.c17.ctg.1	3238	44.4	0	.	p	.	0	I46M	NONSYN	136	138	ATC	244	246	ATG	23;25;26	A;T;G	23;24;26	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	2718	mdtC	3078	3078	98.64	mdtC.l15.c17.ctg.1	3238	44.4	0	.	p	.	0	V208I	NONSYN	622	624	GTC	730	732	ATC	41;41;42	A;T;C	41;39;42	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	2718	mdtC	3078	3078	98.64	mdtC.l15.c17.ctg.1	3238	44.4	0	.	p	.	0	Q980H	NONSYN	2938	2940	CAA	3046	3048	CAC	8;7;7	C;A;C	8;7;7	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	2718	mdtC	3078	3078	98.64	mdtC.l15.c17.ctg.1	3238	44.4	0	.	p	.	0	P981L	NONSYN	2941	2943	CCC	3049	3051	CTC	7;7;7	C;T;C	7;7;7	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1382	mdtD	1416	1416	98.38	mdtD.l15.c30.ctg.1	1878	39.4	0	.	p	.	0	D3E	NONSYN	7	9	GAT	222	224	GAA	19;19;19	G;A;A	19;19;19	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1382	mdtD	1416	1416	98.38	mdtD.l15.c30.ctg.1	1878	39.4	0	.	p	.	0	T226A	NONSYN	676	678	ACG	891	893	GCG	45;45;46	G;C;G	45;45;46	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1382	mdtD	1416	1416	98.38	mdtD.l15.c30.ctg.1	1878	39.4	0	.	p	.	0	V340I	NONSYN	1018	1020	GTC	1233	1235	ATC	56;54;54	A;T;C	56;54;54	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1382	mdtD	1416	1416	98.38	mdtD.l15.c30.ctg.1	1878	39.4	0	.	p	.	0	L441F	NONSYN	1321	1323	TTG	1536	1538	TTT	57;57;56	T;T;T	57;57;56	.	mdtD;Efflux pump mdtD
mdtE.3000795.AP009048.3980025_3981183.753	mdtE.3000795.AP009048.3980025_3981183.753	1	0	27	2222	mdtE	1158	1158	99.31	mdtE.l15.c4.ctg.1	1634	73.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mdtE;MdtE is the membrane fusion protein of the MdtEF multidrug efflux complex. It shares 70% sequence similarity with AcrA.
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	4972	mdtF	3114	3114	98.52	mdtF.l15.c4.ctg.1	3593	74.6	0	.	p	.	0	A295T	NONSYN	883	885	GCC	1126	1128	ACC	56;54;55	A;C,A;C	55;47,2;55	.	mdtF;MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	4972	mdtF	3114	3114	98.52	mdtF.l15.c4.ctg.1	3593	74.6	0	.	p	.	0	N709D	NONSYN	2125	2127	AAT	2368	2370	GAC	105;104;102	G,T;A;C	103,1;103;102	.	mdtF;MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	1226	mdtG	1227	1047	99.33	mdtG.l15.c17.ctg.1	1492	35.9	0	.	p	.	0	V200I	NONSYN	598	600	GTC	649	651	ATC	37;38;38	A;T;C	37;38;38	.	mdtG;Efflux protien mdtG.
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	1226	mdtG	1227	182	99.45	mdtG.l15.c17.ctg.3	370	25.1	0	.	p	.	0	E5G	NONSYN	13	15	GAA	191	193	GGA	9;8;8	G;G;A	9;8;8	.	mdtG;Efflux protien mdtG.
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	1030	mdtH	1209	1209	98.18	mdtH.l15.c30.ctg.1	1585	35.0	0	.	p	.	0	G134C	NONSYN	400	402	GGT	616	618	TGT	47;47;47	T;G;T	47;47;47	.	Multidrug resistance protein MdtH;mdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	1030	mdtH	1209	1209	98.18	mdtH.l15.c30.ctg.1	1585	35.0	0	.	p	.	0	S324L	NONSYN	970	972	TCG	1186	1188	TTG	38;38;38	T;T;G	38;38;38	.	Multidrug resistance protein MdtH;mdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	1030	mdtH	1209	1209	98.18	mdtH.l15.c30.ctg.1	1585	35.0	0	.	p	.	0	A394T	NONSYN	1180	1182	GCG	1396	1398	ACG	17;18;18	A;C;G	17;17;17	.	Multidrug resistance protein MdtH;mdtH
mdtL.3001215.U00096.3891614_3892790.621	mdtL.3001215.U00096.3891614_3892790.621	1	0	539	1828	mdtL	1176	1176	98.38	mdtL.l15.c4.ctg.1	1711	57.6	0	.	p	.	0	A185S	NONSYN	553	555	GCC	796	798	TCC	55;54;53	T;C;C	52;54;52	.	mdtL;Multidrug resistance protein MdtL
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	3296	mfd	3447	3447	99.16	mfd.l15.c4.ctg.1	3838	46.2	0	.	p	.	0	T437K	NONSYN	1309	1311	ACG	1498	1500	AAG	24;27;27	A;A;G	23;27;27	.	mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.;mfd
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	3296	mfd	3447	3447	99.16	mfd.l15.c4.ctg.1	3838	46.2	0	.	p	.	0	M796L	NONSYN	2386	2388	ATG	2575	2577	CTG	45;44;44	C;T;G	44;44;43	.	mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.;mfd
mgrB.3003820.NC_000913.3.1908622_1908766.3586	mgrB.3003820.NC_000913.3.1908622_1908766.3586	1	0	27	236	mgrB	144	144	100.0	mgrB.l15.c17.ctg.2	166	38.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mgrB is a small transmembrane protein produced in the PhoPQ signalling system. It acts as a negative regulator in this system. Inactivation or down-regulation of mgrB confers colistin resistance by absence as shown in Klebsiella pneumoniae;mgrB
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	2206	msbA	1749	1749	98.68	msbA.l15.c30.ctg.1	2094	56.6	0	.	p	.	0	S278N	NONSYN	832	834	AGC	989	991	AAC	55;56;59	A;A;C	55;56;57	.	MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.;msbA
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	2206	msbA	1749	1749	98.68	msbA.l15.c30.ctg.1	2094	56.6	0	.	p	.	0	M460I	NONSYN	1378	1380	ATG	1535	1537	ATA	69;71;72	A;T;A	69;70;72	.	MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.;msbA
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	1700	murA_12	1260	1260	98.49	murA_12.l6.c30.ctg.1	1763	51.8	1	SNP	p	D369N	0	.	.	1105	1107	GAT	1352	1354	GAT	79;78;76	G;A;T	79;78;76	murA.3003775.CP009072.1414817_1416077.3548:1:1:D369N:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	1700	murA_12	1260	1260	98.49	murA_12.l6.c30.ctg.1	1763	51.8	1	SNP	p	L370I	0	.	.	1108	1110	CTG	1355	1357	CTG	75;72;74	C;T;G	75;72;74	murA.3003775.CP009072.1414817_1416077.3548:1:1:L370I:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1574	ompF	1089	1089	99.91	ompF.l15.c30.ctg.1	1575	53.6	0	.	p	.	0	D312E	NONSYN	934	936	GAT	1189	1191	GAG	73;72;71	G;A;G	73;72;71	.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1574	ompF	1089	1089	99.91	ompF.l15.c30.ctg.1	1575	53.6	1	SNP	p	G141D	0	.	.	421	423	GGT	676	678	GGT	90;91;92	G;G;T	90;91;92	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1574	ompF	1089	1089	99.91	ompF.l15.c30.ctg.1	1575	53.6	1	SNP	p	G141E	0	.	.	421	423	GGT	676	678	GGT	90;91;92	G;G;T	90;91;92	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141E:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1574	ompF	1089	1089	99.91	ompF.l15.c30.ctg.1	1575	53.6	1	SNP	p	R154D	0	.	.	460	462	CGT	715	717	CGT	86;83;82	C;G;T,G	86;82;81,1	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1574	ompF	1089	1089	99.91	ompF.l15.c30.ctg.1	1575	53.6	1	SNP	p	R154A	0	.	.	460	462	CGT	715	717	CGT	86;83;82	C;G;T,G	86;82;81,1	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154A:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	5288	parC_2	2259	2259	99.2	parC_2.l15.c4.ctg.1	2726	104.5	0	.	p	.	0	A533V	NONSYN	1597	1599	GCG	1817	1819	GTG	138;140;142	G;T;G	137;140;142	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	5288	parC_2	2259	2259	99.2	parC_2.l15.c4.ctg.1	2726	104.5	0	.	p	.	0	P542S	NONSYN	1624	1626	CCG	1844	1846	TCG	139;140;139	T;C;G	129;136;137	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	5288	parC_2	2259	2259	99.2	parC_2.l15.c4.ctg.1	2726	104.5	0	.	p	.	0	S747N	NONSYN	2239	2241	AGC	2459	2461	AAC	72;71;71	A;A;C	72;71;71	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	5288	parC_2	2259	2259	99.2	parC_2.l15.c4.ctg.1	2726	104.5	1	SNP	p	A85T	0	.	.	253	255	GCG	473	475	GCG	119;120;119	G;C;G	116;119;117	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:A85T:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	5288	parC_2	2259	2259	99.2	parC_2.l15.c4.ctg.1	2726	104.5	1	SNP	p	D111H	0	.	.	331	333	GAT	551	553	GAT	108;108;110	G;A;T	108;107;109	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:D111H:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	5288	parC_2	2259	2259	99.2	parC_2.l15.c4.ctg.1	2726	104.5	1	SNP	p	S129P	0	.	.	385	387	TCC	605	607	TCC	115;115;118	T;C;C,T	115;114;116,1	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:S129P:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	539	3080	parE_1	1893	1893	97.52	parE_1.l15.c4.ctg.1	2155	74.9	0	.	p	.	0	D473N	NONSYN	1417	1419	GAC	1456	1458	AAC	97;96;96	A;A;C	96;96;96	.	Escherichia coli parE conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	539	3080	parE_1	1893	1893	97.52	parE_1.l15.c4.ctg.1	2155	74.9	1	SNP	p	D476N	0	.	.	1426	1428	GAT	1465	1467	GAT	101;99;96	G;A;T	100;98;96	parE.3003316.NC_007779.3172159_3174052.2073:1:1:D476N:.:Point mutation in Escherichia coli parE resulting in fluoroquinolones resistance	Escherichia coli parE conferring resistance to fluoroquinolones
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	3068	patA	1380	1380	99.78	patA.l15.c4.ctg.1	1834	89.7	0	.	p	.	0	P202Q	NONSYN	604	606	CCG	850	852	CAG	115;116;113	C;A,T;G	115;114,1;113	.	PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.;patA
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	3068	patA	1380	1380	99.78	patA.l15.c4.ctg.1	1834	89.7	0	.	p	.	0	E360D	NONSYN	1078	1080	GAG	1324	1326	GAT	93;92;87	G;A;T	93;91;87	.	PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.;patA
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	6324	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4451	76.5	1	SNP	p	V146F	0	.	.	436	438	GTT	656	658	GTT	91;91;92	G;T;T	90;91;92	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:V146F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	6324	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4451	76.5	1	SNP	p	Q513P	0	.	.	1537	1539	CAG	1757	1759	CAG	78;80;79	C;A;G	77;79;79	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	6324	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4451	76.5	1	SNP	p	Q513L	0	.	.	1537	1539	CAG	1757	1759	CAG	78;80;79	C;A;G	77;79;79	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	6324	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4451	76.5	1	SNP	p	H526Y	0	.	.	1576	1578	CAC	1796	1798	CAC	90;90;89	C;A;C	90;90;89	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:H526Y:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	6324	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4451	76.5	1	SNP	p	R529C	0	.	.	1585	1587	CGT	1805	1807	CGT	83;82;83	C;G;T	83;82;82	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529C:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	6324	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4451	76.5	1	SNP	p	R529S	0	.	.	1585	1587	CGT	1805	1807	CGT	83;82;83	C;G;T	83;82;82	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529S:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	6324	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4451	76.5	1	SNP	p	S531F	0	.	.	1591	1593	TCC	1811	1813	TCC	82;79;78	T;C;C	81;79;78	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:S531F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	6324	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4451	76.5	1	SNP	p	L533P	0	.	.	1597	1599	CTC	1817	1819	CTC	74;72;70	C;T;C	74;71;70	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:L533P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	6324	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4451	76.5	1	SNP	p	T563P	0	.	.	1687	1689	ACC	1907	1909	ACC	87;88;91	A;C;C	87;88;91	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:T563P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	6324	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4451	76.5	1	SNP	p	P564L	0	.	.	1690	1692	CCT	1910	1912	CCT	91;95;95	C;C;T	91;95;95	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:P564L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	6324	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4451	76.5	1	SNP	p	R687H	0	.	.	2059	2061	CGT	2279	2281	CGT	121;119;116	C,G;G;T	120,1;118;114	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R687H:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	16890	rrsB+	1542	996	99.8	rrsB+.l15.c30.ctg.2	1226	421.4	0	.	n	.	0	A226G	SNP	226	226	A	456	456	G	581	G	580	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	16890	rrsB+	1542	996	99.8	rrsB+.l15.c30.ctg.2	1226	421.4	0	.	n	.	0	C719T	SNP	719	719	C	949	949	T	419	T,C	187,232	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	16890	rrsB+	1542	996	99.8	rrsB+.l15.c30.ctg.2	1226	421.4	1	SNP	n	A794G	0	.	.	794	794	A	1024	1024	A	449	A	444	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	16890	rrsB+	1542	996	99.8	rrsB+.l15.c30.ctg.2	1226	421.4	1	SNP	n	A794T	0	.	.	794	794	A	1024	1024	A	449	A	444	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	16890	rrsB+	1542	996	99.8	rrsB+.l15.c30.ctg.2	1226	421.4	1	SNP	n	G926T	0	.	.	926	926	G	1156	1156	G	478	G	475	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	16890	rrsB+	1542	996	99.8	rrsB+.l15.c30.ctg.2	1226	421.4	1	SNP	n	G926A	0	.	.	926	926	G	1156	1156	G	478	G	475	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926A:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	16890	rrsB+	1542	996	99.8	rrsB+.l15.c30.ctg.2	1226	421.4	1	SNP	n	G926C	0	.	.	926	926	G	1156	1156	G	478	G	475	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	16890	rrsB+	1542	996	99.8	rrsB+.l15.c30.ctg.2	1226	421.4	0	HET	.	.	.	A253T	.	253	253	A	483	483	A	538	A,T	395,135	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	16890	rrsB+	1542	996	99.8	rrsB+.l15.c30.ctg.2	1226	421.4	0	HET	.	.	.	T90C	.	90	90	T	320	320	T	430	T,C	337,90	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	16890	rrsB+	1542	996	99.8	rrsB+.l15.c30.ctg.2	1226	421.4	0	HET	.	.	.	C194T	.	194	194	C	424	424	C	454	C,T	350,101	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	16890	rrsB+	1542	996	99.8	rrsB+.l15.c30.ctg.2	1226	421.4	0	HET	.	.	.	G474A,C,T	.	474	474	G	704	704	G	518	G,A,C,T	367,145,1,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	16890	rrsB+	1542	996	99.8	rrsB+.l15.c30.ctg.2	1226	421.4	0	HET	.	.	.	A79G	.	79	79	A	309	309	A	441	A,G	337,98	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	16890	rrsB+	1542	996	99.8	rrsB+.l15.c30.ctg.2	1226	421.4	0	HET	.	.	.	T273A,C	.	273	273	T	503	503	T	501	T,A,C	370,115,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	16890	rrsB+	1542	996	99.8	rrsB+.l15.c30.ctg.2	1226	421.4	0	HET	.	.	.	C183T	.	183	183	C	413	413	C	436	C,T	297,136	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	16890	rrsB+	1542	996	99.8	rrsB+.l15.c30.ctg.2	1226	421.4	0	HET	.	.	.	A250T	.	250	250	A	480	480	A	549	A,T	406,136	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	16890	rrsB+	1542	142	100.0	rrsB+.l15.c30.ctg.3	142	127.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	16890	rrsB+	1542	504	100.0	rrsB+.l15.c30.ctg.5	518	585.9	1	SNP	n	A1519G	0	.	.	1519	1519	A	481	481	A	357	A,G	353,1	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	16890	rrsB+	1542	504	100.0	rrsB+.l15.c30.ctg.5	518	585.9	1	SNP	n	A1519T	0	.	.	1519	1519	A	481	481	A	357	A,G	353,1	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	16890	rrsB+	1542	504	100.0	rrsB+.l15.c30.ctg.5	518	585.9	1	SNP	n	A1519C	0	.	.	1519	1519	A	481	481	A	357	A,G	353,1	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	16890	rrsB+	1542	142	95.1	rrsB+.l15.c30.ctg.6	142	85.4	0	.	n	.	0	G1002A	SNP	1002	1002	G	53	53	A	165	A,C	163,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	16890	rrsB+	1542	142	95.1	rrsB+.l15.c30.ctg.6	142	85.4	0	.	n	.	0	G1006C	SNP	1006	1006	G	57	57	C	173	C	172	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	16890	rrsB+	1542	142	95.1	rrsB+.l15.c30.ctg.6	142	85.4	0	.	n	.	0	T1010C	SNP	1010	1010	T	61	61	C	173	C	172	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	16890	rrsB+	1542	142	95.1	rrsB+.l15.c30.ctg.6	142	85.4	0	.	n	.	0	A1019.	DEL	1019	1019	A	69	69	G	165	G	165	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	16890	rrsB+	1542	142	95.1	rrsB+.l15.c30.ctg.6	142	85.4	0	.	n	.	0	.1023G	INS	1023	1023	T	74	74	G	163	G	161	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	16890	rrsB+	1542	142	95.1	rrsB+.l15.c30.ctg.6	142	85.4	0	.	n	.	0	C1038T	SNP	1038	1038	C	89	89	T	131	T	130	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	808	soxR	465	465	100.0	soxR.l15.c4.ctg.1	920	47.2	1	SNP	p	R20H	0	.	.	58	60	CGC	321	323	CGC	77;76;79	C;G;C	75;76;79	soxR.3003381.U00096.4277468_4277933.2074:1:1:R20H:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	808	soxR	465	465	100.0	soxR.l15.c4.ctg.1	920	47.2	1	SNP	p	G121D	0	.	.	361	363	GGT	624	626	GGT	75;74;73	G;G;T	74;74;73	soxR.3003381.U00096.4277468_4277933.2074:1:1:G121D:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxS.3003511.NC_000913.4277059_4277383.3528	soxS.3003511.NC_000913.4277059_4277383.3528	1	1	27	492	soxS_1	324	324	99.69	soxS_1.l6.c4.ctg.1	870	30.5	1	SNP	p	A12S	0	.	.	34	36	GCA	304	306	GCA	71;72;72	G;C;A	70;71;71	soxS.3003511.NC_000913.4277059_4277383.3528:1:1:A12S:.:SoxS is a global regulator that up-regulates the expression of AcrAB efflux genes. It also reduces OmpF expression to decrease cell membrane permeability.	Escherichia coli soxS mutant
tolC.3000237.FJ768952.0_1488.563	tolC.3000237.FJ768952.0_1488.563	1	0	27	3410	tolC	1488	1488	98.72	tolC.l15.c4.ctg.1	1963	93.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	TolC is a protein subunit of many multidrug efflux complexes in Gram negative bacteria. It is an outer membrane efflux protein and is constitutively open. Regulation of efflux activity is often at its periplasmic entrance by other components of the efflux complex.;tolC
